Back to the program

Cervical Cancer Prevention

ThursdayJuly 2nd8:00 - 9:00341

Digital Patient Support for HPV Prevention in Primary Care

Andreea Cristina MACOVEI

In XXX, HPV vaccination uptake remains low, despite cervical cancer continuing to represent a major public health problem. In everyday primary care practice, vaccine hesitancy and limited access to clear, trustworthy information are frequently encountered. Although digital education is increasingly promoted, web-based interventions remain uncommon in XXX.The aim of this study was to assess whether a digitally delivered educational intervention implemented in primary care could improve patient knowledge, attitudes, and confidence regarding HPV vaccination. Also, the study explored subsequent vaccination uptake.This ongoing educational initiative was carried out in one family medicine setting in XXX, with planned expansion to five additional practices before the WONCA conference. Online educational sessions focusing on HPV infection and vaccination were offered to 60 adult patients and parents registered in a single family medicine practice. The sessions were delivered with the involvement of a family medicine trainer and a resident, reflecting routine primary care practice. Knowledge and attitudes were assessed using standardized questionnaires administered before and after the sessions. Follow-up assessments after one and two months are planned to observe changes in attitudes and actual vaccination uptake.Paired analysis included 37 participants who completed both questionnaires, as not all participants completed all study stages. Following the intervention, attitudes towards HPV vaccination improved significantly. Perceived vaccine effectiveness increased, while concerns regarding serious adverse effects decreased (p < 0.01 for both). Adherence to family doctor recommendations also improved. Only 62% of participants completed all assessment stages. These results are preliminary, as data collection is ongoing.The findings suggest that digital education delivered within primary care may help address common concerns related to HPV vaccination. However, incomplete participation highlights practical challenges in maintaining patient follow-up in routine practice.In the digital era, primary care has an important role and digital delivery may increase access to preventive education. This initiative suggests that  teaching delivered through digital platforms can support patient-centered HPV prevention.  This primary care–based digital intervention was associated with more favorable attitudes towards HPV vaccination. Despite being limited to a single practice and a modest sample size, the approach may be transferable to other primary care settings.

HPV literacy among women undergoing chemotherapy for breast cancer: preliminary findings from a cross-sectional study

Feride GULCULER

The level of literacy regarding HPV plays an important role in participation in screening programs and the development of protective behaviors.The aim of this study is to evaluate the levels of literacy regarding HPV infection,cervical cancer screening,and the HPV vaccine in female patients undergoing chemotherapy for breast cancerThis study is prospective,cross-sectional,and descriptive in nature and was conducted between 01/08/2025–01/09/2025,in the chemotherapy unit of a tertiary education and research hospital.Forty-eight female patients receiving chemotherapy for breast cancer were included in the study.Data were collected using a structured form that inquired about sociodemographic and clinical characteristics and the HPV Literacy Scale(HPV-LS) through face-to-face interviews.Statistical analyses were performed using the SPSS 25.0 program;chi-square test,one-way analysis of variance,and appropriate post-hoc tests were used for intergroup comparisons.The significance level was set at p<0.05The mean age of participants was 53.2±9.4 years,64.6% were married,and 43.8% had completed primary school.The proportion of participants who had heard of HPV was 77.1%, and the proportion who reported having knowledge about HPV was 18.8%.The proportion of participants who had received the HPV vaccine was 2.1%.The rate of those who had undergone HPV testing and Pap smears was 64.6%.HPV-LS scores were found to be higher among those who had undergone HPV testing and Pap smears(p=0.022 and p=0.014, respectively),and showed significant differences in terms of education level(p=0.003) and socioeconomic status(p=0.018);while they were found to be lower in individuals with chronic diseases(p=0.032)Findings indicate that HPV literacy is associated with screening behaviors and sociodemographic variables.The significant relationship between participation in screening tests and HPV-LS scores suggests that screening programs should be considered an effective tool for providing information.Differences based on education and socioeconomic status, however, point to inequalities in HPV literacy.These findings are consistent with international studies reporting higher HPV awareness among individuals with higher levels of educationHPV literacy is inadequate among women receiving chemotherapy for breast cancer.The findings suggest that structured interventions to increase HPV awareness,screening counseling,and vaccine awareness in primary care settings should be a priority in health policies Keywords:HPV,Cervical Cancer,HPV Vaccine

The relationship between women's cervical cancer risk status, risk perception, and their cervical cancer screenings

Makbule Neslisah TAN

Cervical cancer screening methods such as the Pap smear and HPV test are easy to administer and are life-saving.In this study, the aim was to determine the relationship between women's cervical cancer risk status and risk perceptions and cervical cancer screening.This cross-sectional study was conducted in April 2021 among 600 women aged 30 to 65 years who met the study criteria and were registered at a university family health centers. Data were collected using a “Data Collection Form” and “The Health Belief Model Scale for Cervical Cancer and the Pap Smear Test”. Participants were asked, "What do you think your risk of cervical cancer is?". Risk perception was measured using 'low,' 'medium,' and 'high' responses. A total risk score was calculated by assigning values to risky health behaviors and situations described in the literature. Statistical analyses included descriptive statistics, t-tests, ANOVA, and chi-square tests.Participants had a mean age of 43.6±10.0 years. Of those who did not undergo screening, 55.5% were aged 30–40 (p = 0.009). Most women (86.2%) knew about cervical cancer screening, and 71.2% had received it. The study found 72.3% perceived medium risk, 20% low, and 7.7% high risk of cervical cancer. Women with high risk perception were more likely to be screened (p = 0.009). Those with higher total risk scores (7.46±2.29) underwent screening more than those with lower scores (6.78±2.48; p = 0.002). No significant difference was found between total risk score and individual risk perception (p > 0.326). Subscale scores—Pap smear benefit/motivation, cancer importance, sensitivity, and health motivation—were higher in women who had Pap smears (34.09±5.84, 24.40±5.98, 8.26±2.42, 9.22±3.20; p = 0.000). Pap smear barriers were higher among unscreened women (41.23±9.65). High-risk perception was linked to higher scores for Pap smear benefit/motivation (36.04±4.20), cancer importance (27.63±5.79), sensitivity (10.20±2.64), and health motivation (10.21±3.22). Low-risk perception corresponded to higher Pap smear barrier scores (35.43±11.69).Consultancy services should be provided to help those with a low risk perception to accurately assess their risk.To understand and assess the risk level of cervical cancer, there is a need to develop risk calculation models.

HPV vaccination coverage and motivators among polish future healthcare providers

Sylwia KALUCKA

Background: HPV vaccination is a key preventive measure against HPV-related cancers, yet uptake among young adults in Poland remains low. Understanding the attitudes and barriers faced by future healthcare professionals is vital for improving coverageAim: To evaluate HPV vaccination coverage, attitudes, and determinants among medical, nursing, midwifery, and public health students, and identify factors influencing vaccination decisions.Methods: A cross-sectional survey was conducted among 1,062 students at the Medical University of Lodz. Participants reported vaccination status, willingness to vaccinate, perceived barriers and motivators, and adverse events. Logistic regression analyses identified predictors of vaccination.Results: Overall, 20% of students had received the HPV vaccine, with the highest coverage among Midwifery students (26.8%) and the lowest among medical students (16.8%). Among unvaccinated students, willingness to vaccinate exceeded 60% in medical students but was below 40% in nursing students. Key barriers included cost and misconceptions about vaccination age limits; most students were too old to benefit from Poland’s recent free vaccination program for 9–14-year-olds. Parental influence and university guidance were the main motivators, though formal recommendations were infrequent. In univariate analysis, marital status, having children, and prior sexual experience were associated with vaccination; in multivariate analysis, only marital status remained significant (OR = 2.58; 95% CI: 1.37–4.86; p = 0.004). Adverse events were reported by 45% of vaccinated students, mostly mild injection-site reactions; no vaccination discontinuations occurred.HPV vaccine uptake among future healthcare professionals in Poland is low despite positive attitudes, highlighting the need for financial support.Conclusions: HPV vaccine uptake among future healthcare professionals in Poland is low despite generally positive attitudes. Targeted educational programs and financial support are needed to reduce barriers and improve vaccination rates, ultimately strengthening preventive healthcare.

Perception of self-sampling for HPV-test by the primary care providers involved in the cervical cancer screening strategy in Lorraine region (France), a qualitative study based on semi-structured interviews

Léa SCHLECK, C. MOURER, C. DUBOURG and S. BARBIER

Despite a national organized screening program since 2018, the incidence of cervical cancer screening rates too low in France. In 2019, national recommendations introduced the use of self sampling for HPV-testing as an alternative to provider-performed screening for women whose screening is not up to date. However, its use appears to be marginal. Numerous studies have examined women's perspectives as well as the technical and budgetary aspects of self-sampling for HPV testing. To date, few studies have examined the opinions of the various prescribers.The objective of this study is to investigate the perception of self-sampling for HPV testing among primary care providers involved in cervical cancer screening in Lorraine (France).Qualitative analysis using semi-structured individual interviews with primary care providers involved in the cervical cancer screening strategy in Lorraine (GPs, midwives, and gynecologists)A total of 13 participants were recruited for the study between July 2024 and March 2025, including 6 general practitioners, 4 midwives, and 3 gynecologists. Most participants reported a positive view of the self sampling for HPV-testing and cited it as a tool to reach some women who had dropped out of screening. However, this test was described it as insufficient and useless in their practice y gynecologists and midwivesThe benefits of self-sampling for HPV-test, already highlighted in the French and internationale literature for patients who have limited access to healthcare or living in rural areas, or having experienced gynecological or sexual trauma. An interesting tension emerged between the potential benefits of such a test for women's empowerment and respect for their privacy, alongside concerns about healthcare professionals losing expertise.Self-sampling for HPV-testing is a promising tool for improving cervical cancer screening by increasing adherence to screening and women's autonomy. However, its widespread adoption requires better promotion and appropriate support to ensure informed use that complements comprehensive medical care.

Retrospective study of CERVICAM (cervical cancer prevention)´s adherence in 3 centers of Madrid region during 2023.

Esperanza TENREIRO VILLAR

The cervical cancer prevalence in Spains is one of the lowest in Europe but in 2016-2020 was increase by a 6%,  in relation with VPH (papiloma human virus) which is present in  the 99,7%.  Been  a silence  cancer until advance stages it´s  important to have a screening method available. In Madrid region it´s  call CERVICAM.  Determinate adherence to Cervical cancer screening by  cervical citology in women between 25 and 65 years old.  Restrospective and descritive observational study that include every women patients  between 25 and 65 years old in  the  3 medical quota and that  had indication of cervical cancer screening.  Principle variable: screening adherence acording to CERVICAM criterias:  - Women between 25 and 35 years old must have a cervical citology each 3 years  - Women between 35 amd 65 years old  must have a negative VPH-AR  or cervical citology in the last 3 years.  Secundary variables:  citology results, VPH results or place where  citology has been taken. 991 patients were include in the study but 50 were  exclude because of the ausence os screening indication obtaining a 55.6% adherence to screening.  The citology results were negative in the 95% but VPH was determinate only un 10.3% of patients.  According to the place were the citology were made 48.5% took place in CERVICAM and 35.2% in the private health care.  The study has shown stadistical difference according to socioeconomic level whith a decrease of adherence from 72.3% to 44.1% between both neighborhoods.  A 55.6% adherence to CERVICAM screening its insufficient to reduce cervical cancer mortality, but it can be related to the lack of information in the general population. Recently the Madrid goverment has modify the CERVICAM protocole  to include the SMS  or email contact o email which. During our study it has been made in some cases telephone contact to inform the patient of the protocole which  increase the adherence in 2024. It could be interesting for forward studies  to compare both porcentages.Telephone contact  and  information of screening as daily medical practice will be necesary to increase cervical cancer  screening adherence and by that reduce its morbimortality